Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Other Non Operating Income (2024 - 2025)

Crinetics Pharmaceuticals has reported Other Non Operating Income over the past 2 years, most recently at -$125000.0 for Q4 2025.

  • Quarterly results put Other Non Operating Income at -$125000.0 for Q4 2025, up 42.66% from a year ago — trailing twelve months through Dec 2025 was -$429000.0 (changed N/A YoY), and the annual figure for FY2025 was -$357000.0, up 31.21%.
  • Other Non Operating Income for Q4 2025 was -$125000.0 at Crinetics Pharmaceuticals, down from -$49000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for CRNX hit a ceiling of -$37000.0 in Q3 2024 and a floor of -$218000.0 in Q4 2024.